title: Gene therapy returns to centre stage.
abstract: Recent clinical trials of gene therapy have shown remarkable therapeutic benefits and an excellent safety record. They provide evidence for the long-sought promise of gene therapy to deliver 'cures' for some otherwise terminal or severely disabling conditions. Behind these advances lie improved vector designs that enable the safe delivery of therapeutic genes to specific cells. Technologies for editing genes and correcting inherited mutations, the engagement of stem cells to regenerate tissues and the effective exploitation of powerful immune responses to fight cancer are also contributing to the revitalization of gene therapy.
authors.affiliation: San Raffaele Telethon Institute for Gene Therapy (TIGET), San Raffaele Scientific Institute, 20132 Milan, Italy.|Vita Salute San Raffaele University, 20132 Milan, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Naldini
mesh_terms: D002986:Clinical Trials as Topic; D018390:Gene Targeting; D015316:Genetic Therapy / Q000379:methods* / Q000639:trends*; D006412:Hematopoietic Stem Cells / Q000378:metabolism; D006801:Humans; D007167:Immunotherapy; D008099:Liver / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009928:Organ Specificity; D013601:T-Lymphocytes / Q000276:immunology / Q000637:transplantation